GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Fatty acid signaling in the pancreatic tumor microenvironment

$486,750
Mara H. Sherman · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA

Fatty acid signaling in the pancreatic tumor microenvironment

$486,750
Mara H. Sherman · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA

Functional analysis of the immune landscape in IDH mutant gliomas

$486,750
Viviane Tabar · Sloan-Kettering Inst Can Research · R21 · FY2021 · NS

Systemic Delivery of Targeted Bi-Compartmental Nanoparticles for Glioblastoma Therapeutics

$486,665
Joerg Lahann · University Of Michigan At Ann Arbor · R01 · FY2022 · NS

Targeting AVIL in Glioblastoma

$486,645
Hui Li · University Of Virginia · R01 · FY2022 · CA

Targeting AVIL in Glioblastoma

$486,645
Hui Li · University Of Virginia · R01 · FY2023 · CA

Immunometabolic pathways enabled by PARP inhibition in breast cancer

$486,593
Jennifer L. Guerriero · Brigham And Women'S Hospital · R37 · FY2025 · CA

NGF recruits nerve fibers to reprogram an immunosuppressive microenvironment in melanoma

$486,559
Xiao-Fan Wang · Duke University · R01 · FY2024 · CA

Investigating the Role of Emergent Oscillations of Hypoxia Inducible Factor-1 alpha Activity in Cancer Growth and Progression

$486,550
Fnu Kshitiz · University Of Connecticut Sch Of Med/Dnt · R37 · FY2023 · CA

Proton-coupled folate/antifolate transport

$486,473
Israel David Goldman · Albert Einstein College Of Medicine, Inc · R01 · FY2015 · CA

Project 04 - Develop a portfolio of agents for switching that match biology of residual tumor burden

$486,458
Douglas Yee · University Of California, San Francisco · P01 · FY2017 · CA

(PQC3) Genomic Diversity and Microenvironment as Drivers of Metastasis in DCIS

$486,312
Eun-Sil Shelley Hwang · Duke University · R01 · FY2014 · CA

A novel role of IGFBP7 in the microenvironment of hepatocellular carcinoma

$486,305
Devanand Sarkar · Virginia Commonwealth University · R01 · FY2020 · CA

A novel role of IGFBP7 in the microenvironment of hepatocellular carcinoma

$486,305
Devanand Sarkar · Virginia Commonwealth University · R01 · FY2021 · CA

Tumor cell metabolism in action

$486,290
Eileen White · Rutgers Biomedical And Health Sciences · R01 · FY2025 · CA

Cell-targeted glutamine antagonists as a novel therapy for lymphoma

$486,249
Barbara Stauch Slusher · Johns Hopkins University · R01 · FY2022 · CA

Metabolic and molecular regulation of myeloid cell functions in brain cancer

$486,185
Filippo Veglia · Wistar Institute · R01 · FY2024 · NS

Chemical Probes for In Vivo Fibrin Imaging

$486,155
Zhaoda Zhang · Massachusetts General Hospital · R01 · FY2017 · CA

TARGETING AML-STROMAL INTERACTIONS

$486,043
John F Dipersio · Washington University · R01 · FY2014 · CA

Defining and targeting epigenetic plasticity-driven drug resistance and immune escape in melanoma

$485,968
Keiran Smalley · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · CA

Mechanistic and therapeutic investigation of secondary metastatic seeding from breast cancer bone lesion

$485,943
Xiang Zhang · Baylor College Of Medicine · R01 · FY2021 · CA

Project 2:Nanoparticle-based Immune Modulators in Cancer Therapy & Vaccines

$485,906
Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · U54 · FY2016 · CA

Anti-oxidant and Metabolic Phenotype in Regulating Tumor Specific T cell Memory Response

$485,903
Shikhar Mehrotra · Medical University Of South Carolina · R01 · FY2024 · CA

Project 1: Combinatorial adjuvants promote uniform and selective intratumoral CTL infiltration in colorectal cancer

$485,860
Pawel Kalinski · Roswell Park Cancer Institute Corp · P01 · FY2020 · CA

Targeting Stromal Influences on Glutamine Addiction in Ovarian Cancer

$485,829
Deepak Nagrath · University Of Michigan At Ann Arbor · R01 · FY2018 · CA